Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LAP3 | P28838 | 5/20 | 0.53 |
| ▸ | ANPEP | P15144 | 2/20 | 0.53 |
| ▸ | ACP3 | P15309 | 5/20 | 0.47 |
| ▸ | MME | P08473 | 2/20 | 0.42 |
| ▸ | ECE1 | P42892 | 2/20 | 0.42 |
| ▸ | AGTR2 | P50052 | 1/20 | 0.42 |
| ▸ | CTSC | P53634 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6575567 | 1.00 | LAP3 (0.53) | LAP3ANPEPACP3MMEECE1 | |
| SCHEMBL7205336 | 0.80 | LAP3 (0.35) | LAP3ANPEPACP3CTSC | |
| SCHEMBL8332677 | 0.78 | LAP3 (0.42) | LAP3ANPEPACP3CTSC | |
| SCHEMBL1655192 | 0.78 | LAP3 (0.58) | LAP3ANPEPACP3MMEECE1 | |
| SCHEMBL7106567 | 0.77 | MME (0.46) | MMEECE1CTSC | |
| SCHEMBL8340029 | 0.76 | SIGMAR1 (0.56) | CTSC | |
| SCHEMBL4314476 | 0.76 | SIGMAR1 (0.56) | CTSC | |
| SCHEMBL1529264 | 0.75 | CTSC (0.46) | LAP3ANPEPMMECTSC | |
| SCHEMBL43351 | 0.75 | MME (0.62) | LAP3ANPEPMMEECE1 | |
| SCHEMBL43350 | 0.75 | MME (0.62) | LAP3ANPEPMMEECE1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0821696-B1 | PEPTIDE ANTAGONISTS OF CELLULAR MITOGENESIS AND MOTOGENESIS AND THEIR THERAPEUTIC USE | PHARMACIA ITALIA SPA (IT) | 2004-05-06 | — | — | EP | disclosed |
| US-6245742-B1 | ANTITUMOR, ANTICARCINOGENIC AND ANTIMETASTASIS AGENTS; VIRICIDES, PSORIASIS, ANTIINFLAMMATORY AGENTS, ANTIALLERGENS, PSORIASIS | PHARMACIA & UPJOHN S.P.A. (IT) | 2001-06-12 | — | — | US | disclosed |
| EP-0768821-A4 | pp60PIK : A DOWNSTREAM ELEMENT IN INSULIN SIGNALING | JOSLIN DIABETES CENTER INC (US) | 1999-10-27 | — | — | EP | disclosed |
| US-5801149-A | PEPTIDS FOR INHIBITION OF PROTEINS | JOSLIN D-ABETES CENTER, INC. (US) | 1998-09-01 | — | — | US | disclosed |
| EP-0821696-A1 | PEPTIDE ANTAGONISTS OF CELLULAR MITOGENESIS AND MOTOGENESIS AND THEIR THERAPEUTIC USE | PHARMACIA & UPJOHN S.p.A. (IT) | 1998-02-04 | — | — | EP | disclosed |
| WO-1997030079-A1 | PEPTIDE ANTAGONISTS OF CELLULAR MITOGENESIS AND MOTOGENESIS AND THEIR THERAPEUTIC USE | PHARMACIA & UPJOHN S.P.A. (IT) | 1997-08-21 | — | — | WO | disclosed |
| US-5650293-A | PROTEIN THAT MEDIATES INSULIN REGULATION OF 3'-PHOSPHATIDYL INOSITOL KINASE WITH NUCLEIC ACID SEQUENCES | JOSLIN DIABETES CENTER, INC. (US) | 1997-07-22 | — | — | US | disclosed |
| EP-0768821-A1 | pp60PIK : A DOWNSTREAM ELEMENT IN INSULIN SIGNALING | THE JOSLIN DIABETES CENTER, INC. (US) | 1997-04-23 | — | — | EP | disclosed |
| WO-1995034201-A1 | pp60PIK: A DOWNSTREAM ELEMENT IN INSULIN SIGNALING | JOSLIN DIABETES CENTER, INC. (US) | 1995-12-21 | — | — | WO | disclosed |
| WO-1994008600-A1 | INHIBITION OF SIGNAL TRANSDUCTION MOLECULES | JOSLIN DIABETES CENTER (US) | 1994-04-28 | — | — | WO | disclosed |